Targeted Chemotherapy with Personalized Immunotherapy, Gebunden
Targeted Chemotherapy with Personalized Immunotherapy
Sie können den Titel schon jetzt bestellen. Versand an Sie erfolgt gleich nach Verfügbarkeit.
- Herausgeber:
- Prasanalakshmi Balaji, Hsin-Yuan Chen, Abhishek Kumar, Chetan Sharma, Prasenjit Das
- Verlag:
- Wiley, 12/2025
- Einband:
- Gebunden
- Sprache:
- Englisch
- ISBN-13:
- 9781394270583
- Artikelnummer:
- 12276845
- Umfang:
- 352 Seiten
- Erscheinungstermin:
- 17.12.2025
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
In the last 20 years, there have been significant leaps forward in the treatment of cancer. We now have a far better understanding of how our cells interact with one another, how cancer suppresses and hides from the immune system, and how to support the body in reacting to stop the spread of cancer. Nevertheless, there is still a great deal more to learn in this field. Researchers are working to develop methods that will help pinpoint the most effective treatment for patients. Through this research, they have discovered that, for certain patients, the best results may be reached by combining precisely targeted chemotherapy with personalized immunotherapy.
Instead of treating patients with medications that are detrimental to the body as a whole, researchers now aim to identify the molecules that play an essential part in the communication that takes place between cells. This study will help pave the way for the development of novel immunotherapies that will help the body in its fight against cancer. In order to accurately plan cancer treatment, participation from a number of different members of the healthcare team is essential. This book is a comprehensive guide for all members of this team, providing insights into groundbreaking new treatments to cure more patients and improve quality of life.
Biografie (Chetan Sharma)
CHETAN SHARMA is Director of R&D at Luminant Worldwide, a leading Internet professional services firm. In this role, he provides vision and strategic direction, directs R&D efforts, and focuses on exploring and evangelizing emerging technologies. He is frequently invited to speak at industry conferences worldwide and is often quoted in media publications. He is also the author of Wireless Internet Enterprise Applications (Wiley) and he holds patents in wireless communications.